Patent · US Active

Palatal drug delivery

US10806675B2 · kind B2 · utility

0Cited by
34References
21Claims
0Family size

Inventor

Key dates

Filing dateAug 30, 2017
Grant dateOct 20, 2020
Priority date
Expiry dateJun 24, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61J7/0092
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Drug delivery devices and systems are disclosed that allow precise, controlled drug delivery via the oral palatal mucosa. The drug delivery devices can be easily used by a patient or other user, and reduce the likelihood of (or in some cases eliminate) dilution of the drug by saliva and fluids and inadvertent swallowing or unplanned uptake of the drug by the patient. The drug delivery devices include a body shaped to conform to a user's palate, and cavities in a palate-facing surface of the body that are configured to receive a drug in liquid form.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.